Cargando…
A 46-Year-Old Woman with a 4-Year History of Graves Disease, with Severe Corticosteroid-Unresponsive Thyroid Eye Disease, Successfully Treated with Tocilizumab
Patient: Female, 46-year-old Final Diagnosis: Graves’ disease Symptoms: Progressive exophthalmos • decreased vision • red and painful eyes • restriction of eye movements bilaterally Medication: Intravenous tocilizumab Clinical Procedure: — Specialty: Ophthalmology OBJECTIVE: Unusual or unexpected ef...
Autores principales: | Almazrouei, Ohood, Alalawi, Fatima, Albrashdi, Safiya, Alsharqi, Hessah, Alsaadi, Ahmed, Hammad, Mondy, Sabri, Alain, Eatamadi, Habibullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939848/ https://www.ncbi.nlm.nih.gov/pubmed/36788719 http://dx.doi.org/10.12659/AJCR.938487 |
Ejemplares similares
-
Tocilizumab use in pediatric thyroid eye disease: First documented case
por: Albrashdi, Safiya, et al.
Publicado: (2022) -
Long‐term outcomes in corticosteroid‐refractory Graves' orbitopathy treated with tocilizumab
por: Moi, Laura, et al.
Publicado: (2021) -
Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
por: Boutzios, Georgios, et al.
Publicado: (2023) -
Conjunctival Sparing Ptosis Correction by White-Line Advancement Technique
por: Habroosh, Fatima A., et al.
Publicado: (2020) -
Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
por: Yamamoto, Koichiro, et al.
Publicado: (2021)